Colton Belluzzo's Gene Therapy Success
This is a news story, published by CBS News, that relates primarily to Belluzzo news.
Belluzzo news
For more Belluzzo news, you can click here:
more Belluzzo newsdisease research news
For more disease research news, you can click here:
more disease research newsCBS News news
For more news from CBS News, you can click here:
more news from CBS NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Colton Belluzzo. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest old northern Minnesota boy news, Colton news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
muscular dystrophyCBS News
•Health
Health
Northern Minnesota boy is first American to receive groundbreaking treatment for muscular dystrophy

73% Informative
Colton Belluzzo was diagnosed with a form of muscular dystrophy when he was 7 months old .
The disease weakens muscles over time, and most people with DMD don't live past the age of 30.
Doctors injected a virus with a gene therapy that slows down the progression of DMD .
The hope is that this therapy will buy time for other treatments.
VR Score
66
Informative language
59
Neutral language
52
Article tone
informal
Language
English
Language complexity
33
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links